• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Alere

Alere agrees to $20m settlement in investor suit

February 6, 2019 By Fink Densford

Abbott‘s (NYSE:ABT) Alere (NYSE:ALR) has agreed to pay $20 million to settle an investor’s suit claiming it made misleading statements about its blood diagnostics business shortly before its proposed billion-dollar merger with Abbott, according to recently released court documents. The suit was originally filed in 2016 by Judith Godinez in the U.S. District Court for the District […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Alere

Medtronic taps former JP Morgan analyst Weinstein for strategy SVP | Personnel Moves – May 7, 2018

May 7, 2018 By Fink Densford

Medtronic (NYSE:MDT) said today it tapped former J.P. Morgan Chase & Co. analyst Mike Weinstein as its strategy senior VP. Prior to joining Medtronic, Weinstein served as a managing director for JP Morgan’s equity research healthcare team, holding positions within the unit for more than 20 years, the Fridley, Minn.-based company said. “We are excited to […]

Filed Under: Business/Financial News Tagged With: Acutus Medical, Alere, Boston Scientific, CareFusion Corp., Endologix, Fresenius, General Electric, Henry Schein Inc., innovheart, Johnson and Johnson, JP Morgan Chase, Medtronic, Patterson Companies

Companies push back against allegations of FCA violations over excess at-home blood testing

April 9, 2018 By Sarah Faulkner

A 70-year-old former Marine is taking a group of companies to court over their at-home blood testing services, arguing that the industry players broke the law by requiring patients to conduct weekly tests. The companies then submit these bills to Medicare for reimbursement, even asking to be repaid for services that weren’t rendered, according to […]

Filed Under: Diagnostics, Legal News, Pharmaceutical, Wall Street Beat Tagged With: Alere, cardiolink, Roche

Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018

April 5, 2018 By Fink Densford

Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Abbott, AdvaMed, Alere, Brightree, Celgene, cerevasc, Cohera Medical Inc., Digirad Corp., IlluminOss Medical Inc., Johnson and Johnson, K2M, ResMed Inc., Smith & Nephew, Stryker, Sunrise Labs, Vascular Insights

Smith & Nephew to name ex-Alere chief exec Nawana as CEO

April 3, 2018 By Fink Densford

Smith & Nephew (NYSE:SNN) is slated to announce tomorrow that it has tapped former Alere (NYSE:ALR) CEO Namal Nawana as its new chief executive officer, according to a report from Sky News. The company has been searching for a replacement since last October, when current head Olivier Bohuon announced plans to retire from the corner office. Bohuon […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Alere, Smith & Nephew

Alere forks over $33m to settle DOJ inquiry

March 23, 2018 By Sarah Faulkner

The U.S. Dept. of Justice said today that Abbott‘s (NYSE:ABT) Alere (NYSE:ALR) agreed to pay $33.2 million to resolve allegations that it knowingly sold unreliable point-of-care diagnostic devices, causing hospitals to submit false claim to Medicare, Medicaid and other federal healthcare programs. The U.S. alleged that Alere sold materially unreliable Triage devices, which are designed to diagnose serious […]

Filed Under: Diagnostics, Legal News, Wall Street Beat Tagged With: Alere

Siemens Healthineers closes Epocal buy

November 1, 2017 By Fink Densford

Siemens (NYSE:SI) Healthineers said today it closed its acquisition of the Epocal point-of-care blood diagnostic business from Alere and Abbott (NYSE:ABT) for an undisclosed amount. Siemens Healthineers said it will integrate Epocal’s portfolio into its POC Ecosystem solution to offer customized testing and touted that the two lines would “integrate seamlessly.” “Health networks have varying needs for blood […]

Filed Under: Business/Financial News, Diagnostics, Mergers & Acquisitions Tagged With: Abbott, Alere, Siemens

Abbott completes Alere tender offer

October 4, 2017 By Fink Densford

Abbott (NYSE:ABT) said today it closed its tender offer for all outstanding Alere (NYSE:ALR) Series B convertible perpetual preferred stock shares at $402 per share. The offer was made in connection with Abbott’s acquisition of Alere, which closed yesterday. A total of 1.7 million shares of preferred stock were tendered in the offer, representing 98.5% of the outstanding […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Abbott, Alere

It’s official: Abbott closes $5B Alere buy

October 3, 2017 By Fink Densford

Abbott (NYSE:ABT) today closed its $5.3 billion buy of diagnostics giant Alere (NYSE:ALR), ending an acquisition process the company has been engaged in since last Feb. The companies received the go-ahead from U.S. and Canadian anti-trust regulators last week, subject to concessions, after having received clearance from EU anti-trust regulators in January. With clearance in hand, the companies […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Abbott, Alere

Abbott’s $5B acquisition of Alere set to close tomorrow

October 2, 2017 By Fink Densford

Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary. The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Abbott, Alere

UPDATE: Abbott plans to close $5B Alere buyout next week

September 29, 2017 By Brad Perriello

UPDATED Sept. 29, 2017, with U.S. Justice Dept. news. Abbott (NYSE:ABT) said today that it plans to close its once star-crossed merger with Alere (NYSE:ALR) next week, after U.S. and Canadian anti-trust regulators yesterday approved the deal subject to concessions. Abbott agreed to divest a blood gas testing system to Siemens (NYSE:SI), which also agreed to buy two […]

Filed Under: Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Alere

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS